Notable Analyst Rating Changes 10/26: (CSTR) (CME) (PG) Upgraded; (CLF) (CAT) (CTCT) Downgraded

October 26, 2012 10:51 AM EDT
UPGRADES
Compass Point boosts Coinstar (Nasdaq: CSTR) from Neutral to Buy with a $50. Click Here for more color.

Raymond James upgrades CME Group (Nasdaq: CME) from Market Perform to Outperform with a price target of $65.

CLSA raises Procter & Gamble (NYSE: PG) from Underperform to Outperform, lifting its price target by $10 to $78.

Credit Suisse lifts CarMax (NYSE: KMX) from Neutral to Outperform.

For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades

DOWNGRADES
Dahlman Rose lowers Cliffs Natural Resources (NYSE: CLF) from Buy to Hold. Click Here for more color.

Goldman Sachs removes Caterpillar (NYSE: CAT) from its Conviction Buy List Friday but maintained a Buy rating and $103 price target. Click Here for more color.

Constant Contact (Nasdaq: CTCT) downgraded by several firms:
  • Needham & Company from Buy to Hold. Click Here for more color;

  • Lazard Capital from Buy to Neutral;

  • Credit Suisse from Outperform to Neutral; and

  • Raymond James from Strong Buy to Market Perform.

Pacific Crest downgrades Electronic Arts (Nasdaq: EA) from Outperform to Sector Perform.

For daily real-time Downgrades go to http://www.streetinsider.com/downgrades

NEW COVERAGE
Brean Capital assumes Varian Medical (NYSE: VAR) at Buy and $80 target. Click Here for more color.

Citi initiates ARIAD Pharmaceuticals (Nasdaq: ARIA) with a Buy and price target of $31.

Credit Suisse reinstates Gulfport Energy (Nasdaq: GPOR) with an Outperform.

Brean Capital commences Accuray (Nasdaq: ARAY) with a Buy and $10 target.

For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage

Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Goldman Sachs Conviction Buy List, Credit Suisse, Citi, Raymond James, Needham & Company, Lazard, Pacific Crest Securities, Notable Analyst Rating Changes